Clinical Trial Update: SGLT2i, Pioglitazone, and Ketone Production in T1D [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial from UT Health San Antonio is evaluating an SGLT2 inhibitor in combination with pioglitazone and its effect on ketone production in peo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• SGLT2 inhibitor (class) (SGLT2 inhibitor)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Type1diabetes | Phase 3 | Status: NOT_YET_RECRUITING